SEC Form 4 · accession 0001804146-26-000004
Pulmonx Corp · LUNG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey Beran Rose
Officer — Chief Commercial Officer
Period of report
Sep 1, 2026
Accepted (ET)
Sep 3, 2026 · 6:17 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001127537
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2026 | S | 2,213 | $2.26 | D | 455,498 | D | |
| Common Stock | Sep 1, 2026 | S | 2,390 | $2.26 | D | 453,108 | D | |
| Common Stock | Sep 1, 2026 | S | 1,530 | $2.26 | D | 451,578 | D | |
| Common Stock | Sep 1, 2026 | S | 1,746 | $2.26 | D | 449,832 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 2, 2026.
- F2These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025.
- F3These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.
- F4These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.